A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
David A Godfrey1, Lee S Peplinski2, Jeanette A Stewart3, William C Stewart31Glaucoma Associates of Texas, Dallas, TX, USA; 2Kentuckiana Institute for Eye Research, Louisville, KY, USA; 3PRN Pharmaceutical Research Network, LLC, Dallas, TX, USAPurpose: To determine the short-term comfort after a sing...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2009
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/9c415153b98b461bb0fe2a32383eb58b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:9c415153b98b461bb0fe2a32383eb58b |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:9c415153b98b461bb0fe2a32383eb58b2021-12-02T00:27:50ZA comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension1177-54671177-5483https://doaj.org/article/9c415153b98b461bb0fe2a32383eb58b2009-01-01T00:00:00Zhttp://www.dovepress.com/a-comfort-comparison-of-travoprost-bak-free-0004-versus-latanoprost-00-a2822https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483David A Godfrey1, Lee S Peplinski2, Jeanette A Stewart3, William C Stewart31Glaucoma Associates of Texas, Dallas, TX, USA; 2Kentuckiana Institute for Eye Research, Louisville, KY, USA; 3PRN Pharmaceutical Research Network, LLC, Dallas, TX, USAPurpose: To determine the short-term comfort after a single dose of travoprost BAK-free compared to latanoprost in primary open-angle glaucoma or ocular hypertensive patients.Design: Prospective, double-masked, randomized comparison of two separate active agents dosed once in opposite eyes.Methods: At Visit 1, qualified patients began a glaucoma medicine-free period for three days. At Visit 2, patients were randomly assigned to travoprost BAK-free or latanoprost in opposite eyes. Following dosing in each eye, patients completed a visual analog scale (VAS score, 0–100 mm) at specified time intervals and a comfort survey.Results: In 54 completed subjects, no difference existed five seconds after dosing, in comfort on the VAS between latanoprost (7.1 ± 16.2 mm) and travoprost BAK-free (7.8 ± 16.1 mm, P = 0.53). Also no differences existed between treatments following dosing for discomfort at individual timepoints past five seconds, peak discomfort or the time required to return to baseline comfort (P > 0.05). In addition, the comfort survey demonstrated no difference between products for burning, stinging, foreign body sensation, overall comfort and general acceptance between the products, both for absolute levels and changes from baseline (P > 0.05).Conclusion: Following a single instillation, both latanoprost and travoprost BAK-free exhibit similar comfort scores.Keywords: comfort, travoprost BAK-free, latanoprost, glaucoma, ocular hypertension David A GodfreyLee S PeplinskiJeanette A StewartWilliam C StewartDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2009, Iss default, Pp 189-194 (2009) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Ophthalmology RE1-994 |
| spellingShingle |
Ophthalmology RE1-994 David A Godfrey Lee S Peplinski Jeanette A Stewart William C Stewart A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension |
| description |
David A Godfrey1, Lee S Peplinski2, Jeanette A Stewart3, William C Stewart31Glaucoma Associates of Texas, Dallas, TX, USA; 2Kentuckiana Institute for Eye Research, Louisville, KY, USA; 3PRN Pharmaceutical Research Network, LLC, Dallas, TX, USAPurpose: To determine the short-term comfort after a single dose of travoprost BAK-free compared to latanoprost in primary open-angle glaucoma or ocular hypertensive patients.Design: Prospective, double-masked, randomized comparison of two separate active agents dosed once in opposite eyes.Methods: At Visit 1, qualified patients began a glaucoma medicine-free period for three days. At Visit 2, patients were randomly assigned to travoprost BAK-free or latanoprost in opposite eyes. Following dosing in each eye, patients completed a visual analog scale (VAS score, 0–100 mm) at specified time intervals and a comfort survey.Results: In 54 completed subjects, no difference existed five seconds after dosing, in comfort on the VAS between latanoprost (7.1 ± 16.2 mm) and travoprost BAK-free (7.8 ± 16.1 mm, P = 0.53). Also no differences existed between treatments following dosing for discomfort at individual timepoints past five seconds, peak discomfort or the time required to return to baseline comfort (P > 0.05). In addition, the comfort survey demonstrated no difference between products for burning, stinging, foreign body sensation, overall comfort and general acceptance between the products, both for absolute levels and changes from baseline (P > 0.05).Conclusion: Following a single instillation, both latanoprost and travoprost BAK-free exhibit similar comfort scores.Keywords: comfort, travoprost BAK-free, latanoprost, glaucoma, ocular hypertension |
| format |
article |
| author |
David A Godfrey Lee S Peplinski Jeanette A Stewart William C Stewart |
| author_facet |
David A Godfrey Lee S Peplinski Jeanette A Stewart William C Stewart |
| author_sort |
David A Godfrey |
| title |
A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension |
| title_short |
A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension |
| title_full |
A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension |
| title_fullStr |
A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension |
| title_full_unstemmed |
A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension |
| title_sort |
comfort comparison of travoprost bak-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension |
| publisher |
Dove Medical Press |
| publishDate |
2009 |
| url |
https://doaj.org/article/9c415153b98b461bb0fe2a32383eb58b |
| work_keys_str_mv |
AT davidagodfrey acomfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension AT leespeplinski acomfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension AT jeanetteastewart acomfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension AT williamcstewart acomfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension AT davidagodfrey comfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension AT leespeplinski comfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension AT jeanetteastewart comfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension AT williamcstewart comfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension |
| _version_ |
1718403755036114944 |